Hantavirus Cluster on Cruise Ship: What You Need to Know
A cluster of hantavirus cases linked to a cruise ship has raised public concern. The World Health Organization (WHO) currently assesses the public health risk as low.
Hantavirus pulmonary syndrome (HPS) is a rare, rodent-borne disease with a high mortality rate, estimated between 35% and 47% . There is no specific antiviral treatment; care focuses entirely on managing symptoms.
Doctor’s Account: A Pediatric Case Study
In July 2022, a 14-year-old patient (Evie) was admitted to Cincinnati Children's Hospital with rapidly progressive respiratory failure. The speed of her decline was startling:
- Within 12 hours, she required mechanical ventilation.
- Within 24 hours, she developed shock and was placed on extracorporeal membrane oxygenation (ECMO) , a heart-lung bypass machine.
"Without ECMO, the patient would not have survived." — Dr. Andrew Lautz, Pediatric ICU Physician
Diagnosis took approximately one week. Doctors considered hantavirus after recognizing the rapid progression and the patient's travel history from North Dakota, where the virus is present. Pulmonary edema was a key symptom.
Treatment and Outcome
Since no direct antiviral exists, ECMO provided critical life support for five days. The case highlights the intense medical demands of HPS:
- The patient suffered cardiac arrest during ECMO cannulation and required nine minutes of chest compressions before heart function resumed.
- After ECMO, she remained on a ventilator for several days before the breathing tube was removed.
- Total hospital stay: Approximately one month (over two weeks in the ICU, 11 days on a general ward).
Dr. Lautz noted that ECMO is not available at all hospitals due to the required surgical expertise and significant risks (e.g., stroke, bleeding, organ dysfunction). Rapid access to a hospital with ECMO capability is critical for survival.
Physician’s Concerns for Cruise Ship Passengers
Dr. Andrew Lautz, the pediatric ICU doctor who treated Evie, emphasized that hantavirus can rapidly progress even in healthy individuals. He expressed specific concern for cruise ship patients regarding their access to critical care.
He noted that the high mortality rate reflects two major challenges:
- The difficulty of diagnosing HPS quickly.
- The challenge of rapidly accessing critical care in remote or mobile settings like a cruise ship.
Key Facts Summary
- Mortality: 35%–47% (per WHO)
- Treatment: No specific cure or antiviral; supportive care only
- Diagnosis: Difficult; testing may not be rapidly available
- Geography: The virus is not endemic to Ohio (the patient contracted it in North Dakota)
- Survival: ECMO was critical for survival in this case
- Public Risk: The WHO states the public health risk from the cruise cluster is low